| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5701097 | European Journal of Surgical Oncology (EJSO) | 2017 | 6 Pages |
Abstract
AML manifests as at least two different entities with significantly different outcomes. Epithelioid subtype, poor/non-fatty features, and renal vein involvement are all associated with worse survival.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
J.-B. Delhorme, A. Fontana, A. Levy, P. Terrier, M. Fiore, D. Tzanis, D. Callegaro, C. Dratwa, A. Gronchi, S. Bonvalot,